A marketplace, similar to a luxury consignment shop, where individuals who have successfully undergone gene-editing therapy for cancer can donate or resell byproducts (e.g., excess engineered immune cells, data insights) to research institutions or individuals in need. Ensures that valuable resources are not wasted and potentially offers a discounted access route for certain components of the therapy, within strict regulatory safety standards.